Beam Therapeutics Inc (NASDAQ:BEAM) price on Thursday, April 10, fall -10.63% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $14.63. A look at the stock’s price movement, the close in the last trading session was $16.37. Turning
Beam Therapeutics Inc (NASDAQ:BEAM) price closed higher on Monday, April 07, and jumping 0.20% above its previous close. A look at the daily price movement shows that the last close reads $15.27, with intraday deals fluctuated between $13.525 and $16.01. The company’s 5Y monthly beta
Beam Therapeutics Inc (NASDAQ:BEAM) concluded the trading at $16.46 on Thursday, April 03 with a fall of -10.93% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $18.48 and 5Y monthly beta
Beam Therapeutics Inc (NASDAQ:BEAM) traded at $22.21 at close of the session on Friday, March 28 and made an upward move of 0.09% on its previous day’s price. Looking at the stock we see that its previous close was $22.19 and the beta (5Y monthly)
Beam Therapeutics Inc (NASDAQ:BEAM) shares, rose in value on Wednesday, March 26, with the stock price down by -5.64% to the previous day’s close as strong demand from buyers drove the stock to $21.91. Actively observing the price movement in the last trading, the stock
The trading price of Beam Therapeutics Inc (NASDAQ:BEAM) closed higher on Friday, March 21, and closing at $23.30, 1.88% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $22.14 and $23.43. In examining the
Beam Therapeutics Inc (NASDAQ:BEAM) price on current trading day, rose 4.65% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $23.64. A look at the stock’s price movement, the close in the last trading session was $22.59, moving
Beam Therapeutics Inc (NASDAQ:BEAM) price closed lower on current market day and dropping -3.31% below its previous close. A look at the daily price movement shows that the last close reads $25.06, with intraday deals fluctuated between $23.94 and $25.805. The company’s 5Y monthly beta
Beam Therapeutics Inc (NASDAQ:BEAM) traded at $28.48 at close of the session on Friday, March 07 and made an upward move of 4.51% on its previous day’s price. Beam Therapeutics Inc has a market cap of $2.38 billion and is expected to release its quarterly
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
